Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$138.42 - $180.31 $25.9 Million - $33.8 Million
-187,395 Reduced 100.0%
4 $0
Q1 2023

May 15, 2023

SELL
$154.26 - $198.1 $457,843 - $587,960
-2,968 Reduced 1.56%
187,399 $31.6 Million
Q4 2022

Feb 14, 2023

SELL
$162.42 - $220.56 $182,397 - $247,688
-1,123 Reduced 0.59%
190,367 $32.2 Million
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $4.51 Million - $7.2 Million
-28,093 Reduced 12.79%
191,490 $35.8 Million
Q2 2022

Aug 15, 2022

SELL
$140.68 - $188.02 $459,601 - $614,261
-3,267 Reduced 1.47%
219,583 $35.7 Million
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $35.1 Million - $56.2 Million
-217,715 Reduced 49.42%
222,850 $41.9 Million
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $2.86 Million - $3.52 Million
-11,571 Reduced 2.56%
440,565 $117 Million
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $2.7 Million - $4.5 Million
-13,865 Reduced 2.98%
452,136 $131 Million
Q2 2021

Aug 16, 2021

SELL
$165.87 - $220.95 $314,821 - $419,363
-1,898 Reduced 0.41%
466,001 $93 Million
Q1 2021

May 17, 2021

SELL
$180.37 - $226.26 $2.3 Million - $2.88 Million
-12,726 Reduced 2.65%
467,899 $91 Million
Q4 2020

Feb 16, 2021

SELL
$148.08 - $206.57 $344,730 - $480,894
-2,328 Reduced 0.48%
480,625 $92.1 Million
Q3 2020

Nov 16, 2020

SELL
$122.51 - $158.27 $1.47 Million - $1.9 Million
-11,999 Reduced 2.42%
482,953 $71.3 Million
Q2 2020

Aug 14, 2020

SELL
$94.33 - $140.48 $1.82 Million - $2.71 Million
-19,314 Reduced 3.76%
494,952 $61.2 Million
Q1 2020

May 15, 2020

SELL
$84.96 - $109.14 $1.59 Million - $2.04 Million
-18,664 Reduced 3.5%
514,266 $49.6 Million
Q4 2019

Feb 14, 2020

BUY
$73.84 - $93.08 $39.4 Million - $49.6 Million
532,930 New
532,930 $49.3 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.94B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.